An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania major

BACKGROUND: Protozoan parasites from the genus Leishmania cause broad clinical manifestations known as leishmaniases, which affect millions of people worldwide. Cutaneous leishmaniasis (CL), caused by L. major, is one the most common forms of the disease in the Old World. There is no preventive or t...

Descripción completa

Detalles Bibliográficos
Autores principales: Iniguez, Eva, Schocker, Nathaniel S., Subramaniam, Krishanthi, Portillo, Susana, Montoya, Alba L., Al-Salem, Waleed S., Torres, Caresse L., Rodriguez, Felipe, Moreira, Otacilio C., Acosta-Serrano, Alvaro, Michael, Katja, Almeida, Igor C., Maldonado, Rosa A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673233/
https://www.ncbi.nlm.nih.gov/pubmed/29069089
http://dx.doi.org/10.1371/journal.pntd.0006039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673233/
https://www.ncbi.nlm.nih.gov/pubmed/29069089
http://dx.doi.org/10.1371/journal.pntd.0006039

Ejemplares similares